Last updated on November 2017

Multi-center, double-blind, double-dummy, randomized, placebo- and active-reference, parallel group, Phase 2 dose-finding study with ACT-132577 in subjects with essential hypertension (grade 1 and 2)


Brief description of study

Multi-center, double-blind, double-dummy, randomized, placebo- and active-reference, parallel group, Phase 2 dose-finding study with ACT-132577 in subjects with essential hypertension (grade 1 and 2)

Detailed Study Description

The primary objective of the study is to explore 4 doses of ACT-132577 on diastolic blood pressure (DBP) in subjects with essential hypertension (grade 1 and 2).

Clinical Study Identifier: TX11292

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jeffrey D. Wayne, MD

Clinical Trials Research
Lincoln, CA USA
  Connect »